GMED reported its earnings on 2026-02-24, showcasing a revenue of 826.42M against an estimate of 787.85M, resulting in a 4.9% surprise. The EPS was 1.28, surpassing the expected 1.06 by 20.75%. The stock experienced a 4.72% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.